Published in Biometrics on December 01, 2010
A Semi-stationary Copula Model Approach for Bivariate Survival Data with Interval Sampling. Int J Biostat (2015) 0.76
Nonparametric analysis of bivariate gap time with competing risks. Biometrics (2016) 0.75
Nonparametric methods for analyzing recurrent gap time data with application to infections after hematopoietic cell transplant. Biometrics (2015) 0.75
Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med (1990) 11.57
Inferences on the association parameter in copula models for bivariate survival data. Biometrics (1995) 3.77
Multi-state models: a review. Lifetime Data Anal (1999) 1.55
A concordance test for independence in the presence of censoring. Biometrics (1982) 1.39
Course of illness in depressive and bipolar disorders. Naturalistic study, 1994-1999. Br J Psychiatry (2004) 1.31
Flexible maximum likelihood methods for bivariate proportional hazards models. Biometrics (2003) 0.89
An extension of Kendall's coefficient of concordance to bivariate interval censored data. Stat Med (1999) 0.83
Non-parametric estimation and model checking procedures for marginal gap time distributions for recurrent events. Stat Med (2007) 0.83
Local likelihood analysis of the latency distribution with interval censored intermediate events. Stat Med (2002) 0.82
Rare-variant association testing for sequencing data with the sequence kernel association test. Am J Hum Genet (2011) 18.88
Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med (2008) 18.60
LKB1 modulates lung cancer differentiation and metastasis. Nature (2007) 7.80
Powerful SNP-set analysis for case-control genome-wide association studies. Am J Hum Genet (2010) 6.60
Optimal unified approach for rare-variant association testing with application to small-sample case-control whole-exome sequencing studies. Am J Hum Genet (2012) 5.48
A powerful and flexible multilocus association test for quantitative traits. Am J Hum Genet (2008) 4.96
Aberrant lipid metabolism disrupts calcium homeostasis causing liver endoplasmic reticulum stress in obesity. Nature (2011) 4.78
Optimal tests for rare variant effects in sequencing association studies. Biostatistics (2012) 4.69
Semiparametric regression of multidimensional genetic pathway data: least-squares kernel machines and linear mixed models. Biometrics (2007) 4.66
Estimation and testing for the effect of a genetic pathway on a disease outcome using logistic kernel machine regression via logistic mixed models. BMC Bioinformatics (2008) 3.70
Hypothesis testing in semiparametric additive mixed models. Biostatistics (2003) 3.63
Bone turnover markers as predictors of skeletal complications in prostate cancer, lung cancer, and other solid tumors. J Natl Cancer Inst (2005) 3.08
Systematic review: efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura. Ann Intern Med (2007) 2.97
Methodologic issues in the use of bleeding as an outcome in transfusion medicine studies. Transfusion (2003) 2.48
Sequence kernel association tests for the combined effect of rare and common variants. Am J Hum Genet (2013) 2.41
Genetic variants on 15q25.1, smoking, and lung cancer: an assessment of mediation and interaction. Am J Epidemiol (2012) 2.16
Risk factors for hip fracture in older home care clients. J Gerontol A Biol Sci Med Sci (2009) 2.15
SNP set association analysis for familial data. Genet Epidemiol (2012) 2.08
Semiparametric modeling of longitudinal measurements and time-to-event data--a two-stage regression calibration approach. Biometrics (2008) 2.05
Zoledronic acid and survival in patients with metastatic bone disease from lung cancer and elevated markers of osteoclast activity. J Thorac Oncol (2008) 1.98
VEGF polymorphisms and survival in early-stage non-small-cell lung cancer. J Clin Oncol (2008) 1.94
General framework for meta-analysis of rare variants in sequencing association studies. Am J Hum Genet (2013) 1.86
Mixtures of varying coefficient models for longitudinal data with discrete or continuous nonignorable dropout. Biometrics (2004) 1.85
Impact of physician asthma care education on patient outcomes. Pediatrics (2006) 1.70
A comparison of methods for estimating the causal effect of a treatment in randomized clinical trials subject to noncompliance. Biometrics (2008) 1.70
A varying-coefficient Cox model for the effect of age at a marker event on age at menopause. Biometrics (2005) 1.68
Clinical presentation, recurrence, and survival in patients with neuroendocrine tumors: results from a prospective institutional database. Endocr Relat Cancer (2013) 1.62
Family-based association tests for sequence data, and comparisons with population-based association tests. Eur J Hum Genet (2013) 1.55
Genome-wide analysis of survival in early-stage non-small-cell lung cancer. J Clin Oncol (2009) 1.52
Reliability of electrocardiogram interpretation in critically ill patients. Crit Care Med (2006) 1.51
External validation of a risk assessment model for venous thromboembolism in the hospitalised acutely-ill medical patient (VTE-VALOURR). Thromb Haemost (2014) 1.49
A tobit variance-component method for linkage analysis of censored trait data. Am J Hum Genet (2003) 1.49
The effect of correlation in false discovery rate estimation. Biometrika (2011) 1.46
Scaled marginal models for multiple continuous outcomes. Biostatistics (2003) 1.46
Air pollution-associated changes in lung function among asthmatic children in Detroit. Environ Health Perspect (2005) 1.45
The effect of rituximab on vaccine responses in patients with immune thrombocytopenia. Blood (2013) 1.44
Anti-platelet factor 4/heparin antibodies in orthopedic surgery patients receiving antithrombotic prophylaxis with fondaparinux or enoxaparin. Blood (2005) 1.43
Finding disease variants in Mendelian disorders by using sequence data: methods and applications. Am J Hum Genet (2011) 1.40
Statistical methods for multivariate interval-censored recurrent events. Stat Med (2005) 1.38
Studies of the immune response in heparin-induced thrombocytopenia. Blood (2009) 1.37
Analysis of interval-censored disease progression data via multi-state models under a nonignorable inspection process. Stat Med (2010) 1.35
Detecting rare variant effects using extreme phenotype sampling in sequencing association studies. Genet Epidemiol (2012) 1.35
Cardiovascular and other comorbidities in patients with psoriatic arthritis: a comparison with patients with psoriasis. Arthritis Care Res (Hoboken) (2011) 1.35
Ascertainment-adjusted parameter estimates revisited. Am J Hum Genet (2002) 1.34
Genotypes and haplotypes of matrix metalloproteinase 1, 3 and 12 genes and the risk of lung cancer. Carcinogenesis (2005) 1.33
Sparse linear discriminant analysis for simultaneous testing for the significance of a gene set/pathway and gene selection. Bioinformatics (2009) 1.32
Semiparametric Maximum Likelihood Estimation in Normal Transformation Models for Bivariate Survival Data. Biometrika (2008) 1.31
The role of choice in health education intervention trials: a review and case study. Soc Sci Med (2003) 1.30
Kernel machine approach to testing the significance of multiple genetic markers for risk prediction. Biometrics (2011) 1.30
Genome-wide association analysis for multiple continuous secondary phenotypes. Am J Hum Genet (2013) 1.29
Kernel machine SNP-set analysis for censored survival outcomes in genome-wide association studies. Genet Epidemiol (2011) 1.29
The risk of bleeding in thrombocytopenic patients with acute myeloid leukemia. Haematologica (2006) 1.27
Staging reproductive aging: a comparison of proposed bleeding criteria for the menopausal transition. Menopause (2004) 1.27
Progression of subclinical coronary atherosclerosis: does obesity make a difference? Circulation (2005) 1.27
A randomized controlled trial comparing standard- and low-dose strategies for transfusion of platelets (SToP) to patients with thrombocytopenia. Blood (2008) 1.25
Vascular endothelial growth factor genotypes, haplotypes, gender, and the risk of non-small cell lung cancer. Clin Cancer Res (2008) 1.24
Tests for multivariate recurrent events in the presence of a terminal event. Biostatistics (2004) 1.24
A pilot randomized trial of adjuvant rituximab or placebo for nonsplenectomized patients with immune thrombocytopenia. Blood (2012) 1.22
Quantitative quality-assessment techniques to compare fractionation and depletion methods in SELDI-TOF mass spectrometry experiments. Bioinformatics (2007) 1.22
Test for interactions between a genetic marker set and environment in generalized linear models. Biostatistics (2013) 1.20
Exposure to airborne particulate matter is associated with methylation pattern in the asthma pathway. Epigenomics (2013) 1.17
A multicenter pilot-randomized controlled trial of the feasibility of an augmented red blood cell transfusion strategy for patients treated with induction chemotherapy for acute leukemia or stem cell transplantation. Transfusion (2007) 1.17
Neuropsychological effects of low-level manganese exposure in welders. Neurotoxicology (2010) 1.16
Zoledronic acid and survival in breast cancer patients with bone metastases and elevated markers of osteoclast activity. Oncologist (2007) 1.16
Regression analysis of multivariate panel count data. Biostatistics (2007) 1.15
Apoptosis gene polymorphisms, age, smoking and the risk of non-small cell lung cancer. Carcinogenesis (2008) 1.15
GEE-based SNP set association test for continuous and discrete traits in family-based association studies. Genet Epidemiol (2013) 1.14
Variation in folate pathway genes contributes to risk of congenital heart defects among individuals with Down syndrome. Genet Epidemiol (2010) 1.14
Risk factors for low bone mineral density and the 6-year rate of bone loss among premenopausal and perimenopausal women. Osteoporos Int (2004) 1.13
Toenail, blood, and urine as biomarkers of manganese exposure. J Occup Environ Med (2011) 1.12
A Large-scale genetic association study of esophageal adenocarcinoma risk. Carcinogenesis (2010) 1.12
International spondyloarthritis interobserver reliability exercise--the INSPIRE study: II. Assessment of peripheral joints, enthesitis, and dactylitis. J Rheumatol (2007) 1.11
Evaluation of Viable Dynamic Treatment Regimes in a Sequentially Randomized Trial of Advanced Prostate Cancer. J Am Stat Assoc (2012) 1.11
The clinical assessment of patients with psoriatic arthritis: results of a reliability study of the spondyloarthritis research consortium of Canada. J Rheumatol (2004) 1.10
Sparse principal component analysis for identifying ancestry-informative markers in genome-wide association studies. Genet Epidemiol (2012) 1.10
Two-stage functional mixed models for evaluating the effect of longitudinal covariate profiles on a scalar outcome. Biometrics (2007) 1.09
Natural history of malignant bone disease in breast cancer and the use of cumulative mean functions to measure skeletal morbidity. BMC Cancer (2009) 1.09
Missing covariates in longitudinal data with informative dropouts: bias analysis and inference. Biometrics (2005) 1.09
Predictors of skeletal complications in men with hormone-refractory metastatic prostate cancer. Urology (2007) 1.08
Soluble biomarkers differentiate patients with psoriatic arthritis from those with psoriasis without arthritis. Rheumatology (Oxford) (2010) 1.08
Using eQTL weights to improve power for genome-wide association studies: a genetic study of childhood asthma. Front Genet (2013) 1.08
Increased power for the analysis of label-free LC-MS/MS proteomics data by combining spectral counts and peptide peak attributes. Mol Cell Proteomics (2010) 1.08
A descriptive analysis of international transfusion practice and bleeding outcomes in patients with acute leukemia. Transfusion (2006) 1.06
Variable selection and estimation in generalized linear models with the seamless L0 penalty. Can J Stat (2012) 1.06
Fetal window of vulnerability to airborne polycyclic aromatic hydrocarbons on proportional intrauterine growth restriction. PLoS One (2012) 1.06
Duration of red cell storage before transfusion and in-hospital mortality. Am Heart J (2010) 1.06
Prognostic factors for skeletal complications from metastatic bone disease in breast cancer. Breast Cancer Res Treat (2010) 1.05
Cigarette smoking increases copy number alterations in nonsmall-cell lung cancer. Proc Natl Acad Sci U S A (2011) 1.05
International spondyloarthritis interobserver reliability exercise--the INSPIRE study: I. Assessment of spinal measures. J Rheumatol (2007) 1.04
Identifying genetic marker sets associated with phenotypes via an efficient adaptive score test. Biostatistics (2012) 1.04
Arsenic reduction in drinking water and improvement in skin lesions: a follow-up study in Bangladesh. Environ Health Perspect (2012) 1.03
Interictal epileptiform discharges do not change before seizures during sleep. Epilepsia (2002) 1.03
Avoiding transfusions in children undergoing cardiac surgery: a meta-analysis of randomized trials of aprotinin. Anesth Analg (2006) 1.03
The effect of blood storage duration on in-hospital mortality: a randomized controlled pilot feasibility trial. Transfusion (2012) 1.03
International multicenter psoriasis and psoriatic arthritis reliability trial for the assessment of skin, joints, nails, and dactylitis. Arthritis Rheum (2009) 1.02
Prognostic significance of MTOR pathway component expression in neuroendocrine tumors. J Clin Oncol (2013) 1.02
Clinical utility of biochemical markers of bone metabolism for improving the management of patients with advanced multiple myeloma. Clin Lymphoma Myeloma (2007) 1.02
Utilization of platelet transfusions in the intensive care unit: indications, transfusion triggers, and platelet count responses. Transfusion (2006) 1.02
Do patients with psoriatic arthritis who present early fare better than those presenting later in the disease? Ann Rheum Dis (2011) 1.02